Literature DB >> 11328727

Expression and localization of angiogenic inhibitory factor, chondromodulin-I, in adult rat eye.

H Funaki1, S Sawaguchi, K Yaoeda, Y Koyama, E Yaoita, S Funaki, M Shirakashi, Y Oshima, C Shukunami, Y Hiraki, H Abe, T Yamamoto.   

Abstract

PURPOSE: To determine the role in the eye of chondromodulin (ChM)-I, which has been identified in cartilage as an angiogenic inhibitor, the expression and localization and a possible function of ChM-I were investigated.
METHODS: Expression and localization of ChM-I in rat eyes were examined by RNase protection assay and in situ hybridization and by immunostaining, using an antibody against a synthetic peptide. The effect of recombinant ChM-I on tube morphogenesis of retinal endothelial cells was examined in culture.
RESULTS: The rat ChM-I gene was determined to encode the open reading frame of 334 amino acid residues, and ChM-I mRNA was exclusively expressed in cartilage, eye, and cerebellum in rats. ChM-I mRNA expression was evident in the iris-ciliary body, retina, and scleral compartments, but not in other compartments of the eye. In situ hybridization revealed mRNA expression in the ganglion cells, inner nuclear layer cells, and pigment epithelium in the retina and in the nonpigment epithelium of the ciliary body. Immunoreactive ChM-I was present in these cells and also in the vitreous body. Western blot analysis detected an approximately 25-kDa band of ChM-I presumed as a secretory form in the aqueous humor and vitreous body and an approximately 37-kDa band as a precursor form in the retina. Recombinant human ChM-I inhibited tube morphogenesis of human retinal endothelial cells in vitro.
CONCLUSIONS: These observations indicate a potential role for ChM-I in inhibition of angiogenesis in the rat eye.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328727

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Dietary blueberry supplementation affects growth but not vascularization of neural transplants.

Authors:  Lauren M Willis; Brent J Small; Paula C Bickford; Claudia D Umphlet; Alfred B Moore; Ann-Charlotte E Granholm
Journal:  J Cereb Blood Flow Metab       Date:  2008-02-20       Impact factor: 6.200

2.  Translational vitreous proteomics.

Authors:  Vinit B Mahajan; Jessica M Skeie
Journal:  Proteomics Clin Appl       Date:  2013-11-04       Impact factor: 3.494

3.  Tenomodulin is necessary for tenocyte proliferation and tendon maturation.

Authors:  Denitsa Docheva; Ernst B Hunziker; Reinhard Fässler; Oliver Brandau
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  A high-fat/high-cholesterol diet inhibits growth of fetal hippocampal transplants via increased inflammation.

Authors:  L R Freeman; B J Small; P C Bickford; C Umphlet; A-Ch Granholm
Journal:  Cell Transplant       Date:  2011-03-07       Impact factor: 4.064

5.  Inhibitory effect of tenomodulin versus ranibizumab on in vitro angiogenesis.

Authors:  Wei Wang; Guang-Xu Liu; Yue-Hua Li; Xue-Dong Li; Yan He
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

6.  4-HNE inhibits tube formation and up-regulates chondromodulin-I in human endothelial cells.

Authors:  Dimitrios Stagos; Hongfei Zhou; David Ross; Vasilis Vasiliou
Journal:  Biochem Biophys Res Commun       Date:  2008-12-03       Impact factor: 3.575

7.  Chondromodulin I is dispensable during enchondral ossification and eye development.

Authors:  Oliver Brandau; Attila Aszódi; Ernst B Hunziker; Peter J Neame; Dietmar Vestweber; Reinhard Fässler
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I.

Authors:  Shigenori Miura; Jun Kondo; Toru Kawakami; Chisa Shukunami; Saburo Aimoto; Hideyuki Tanaka; Yuji Hiraki
Journal:  Cancer Sci       Date:  2012-04-27       Impact factor: 6.716

9.  Localization of chondromodulin-I at the feto-maternal interface and its inhibitory actions on trophoblast invasion in vitro.

Authors:  Shigenori Miura; Chisa Shukunami; Kaori Mitsui; Jun Kondo; Yuji Hiraki
Journal:  BMC Cell Biol       Date:  2011-08-18       Impact factor: 4.241

10.  Tenomodulin inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.

Authors:  Wei Wang; Zhongqiu Li; Tatsuhiko Sato; Yusuke Oshima
Journal:  Int J Mol Sci       Date:  2012-11-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.